Aryl-linked imidazolidin-2-ones as non-peptidic β-strand mimetics.

Chem Commun (Camb)

Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, UK.

Published: October 2012

We describe the design and synthesis of a non-peptidic β-strand mimetic composed of alternating aryl and imidazolidin-2-one rings that can be adapted to display diverse side-chains. Solid- and solution-phase data together with calculations suggest that the desired conformation for side-chain mimicry is readily accessible and well-populated.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c2cc34791aDOI Listing

Publication Analysis

Top Keywords

non-peptidic β-strand
8
aryl-linked imidazolidin-2-ones
4
imidazolidin-2-ones non-peptidic
4
β-strand mimetics
4
mimetics describe
4
describe design
4
design synthesis
4
synthesis non-peptidic
4
β-strand mimetic
4
mimetic composed
4

Similar Publications

Sortase A-mediated ligation (SML) or "sortagging" has become a popular technology to selectively introduce structurally diverse protein modifications. Despite the great progress in the optimization of the reaction conditions and design of miscellaneous C- or N-terminal protein modification strategies, the reported yields of conjugates are highly variable. In this study, we have systematically investigated C-terminal protein sortagging efficiency using a combination of several rationally selected and modified acceptor proteins and a panel of incoming surrogate non-peptidic amine nucleophile substrates varying in the structural features of their amino linker parts and cargo molecules.

View Article and Find Full Text PDF

Conformational Plasticity and Binding Affinity Enhancement Controlled by Linker Derivatization in Macrocycles.

Angew Chem Int Ed Engl

January 2025

Darmstadt University of Technology: Technische Universitat Darmstadt, Clemens-Schöpf-Institute of Organic Chemistry and Biochemistry, Alarich-Weiss-Strasse 4, 64287, Darmstadt, GERMANY.

Article Synopsis
  • Macrocycles are natural and synthetic compounds that can enhance the ability of bioactive molecules to penetrate cells, with emerging guidelines for their design.
  • Even medium-sized macrocycles exhibit significant flexibility in shape, even while attached to target proteins, which allows for diverse conformations.
  • Minor linker modifications in these macrocycles can lead to new ligand formations with improved binding properties for important therapeutic targets, highlighting the unique benefits of macrocyclic structures in drug development.
View Article and Find Full Text PDF

Design of Small Non-Peptidic Ligands That Alter Heteromerization between Cannabinoid CB and Serotonin 5HT Receptors.

J Med Chem

January 2025

Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona 08028, Spain.

Activation of cannabinoid CB receptors (CBR) by agonists induces analgesia but also induces cognitive impairment through the heteromer formed between CBR and the serotonin 5HT receptor (5HTR). This side effect poses a serious drawback in the therapeutic use of cannabis for pain alleviation. Peptides designed from the transmembrane helices of CBR, which are predicted to bind 5HTR and alter the stability of the CBR-5HTR heteromer, have been shown to avert CBR agonist-induced cognitive impairment while preserving analgesia.

View Article and Find Full Text PDF

An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo.

Cell Rep

November 2024

Department of Biochemistry & Biophysics, Texas A&M University, College Station, TX 77840, USA. Electronic address:

Safe, effective, and low-cost oral antiviral therapies are needed to treat those at high risk for developing severe COVID-19. To that end, we performed a high-throughput screen to identify non-peptidic, non-covalent inhibitors of the SARS-CoV-2 main protease (Mpro), an essential enzyme in viral replication. NZ-804 was developed from a screening hit through iterative rounds of structure-guided medicinal chemistry.

View Article and Find Full Text PDF

Secondary hyperparathyroidism is one of the most frequent metabolic abnormalities found in patients with chronic kidney disease. The calcium-sensing receptor senses extracellular calcium and is the principal regulator of parathyroid hormone secretion. Cloning of the calcium-sensing receptor led to the development of calcimimetics, drugs that decrease parathyroid hormone secretion through the positive allosteric modulation of this receptor.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!